img

Follicle-stimulating Hormone (FSH) Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 105 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Follicle-stimulating Hormone (FSH) Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Follicle-stimulating Hormone (FSH) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Follicle-stimulating Hormone (FSH) market segmented into
Recombinant FSH
Urinary FSH

Based on the end-use

the global Follicle-stimulating Hormone (FSH) market classified into
Infertility Treatment
Assisted Reproductive Technology

Based on geography

the global Follicle-stimulating Hormone (FSH) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL FOLLICLE-STIMULATING HORMONE (FSH) INDUSTRY
2.1 Summary about Follicle-stimulating Hormone (FSH) Industry
2.2 Follicle-stimulating Hormone (FSH) Market Trends
2.2.1 Follicle-stimulating Hormone (FSH) Production & Consumption Trends
2.2.2 Follicle-stimulating Hormone (FSH) Demand Structure Trends
2.3 Follicle-stimulating Hormone (FSH) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant FSH
4.2.2 Urinary FSH
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Infertility Treatment
4.3.2 Assisted Reproductive Technology
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant FSH
5.2.2 Urinary FSH
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Infertility Treatment
5.3.2 Assisted Reproductive Technology
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant FSH
6.2.2 Urinary FSH
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Infertility Treatment
6.3.2 Assisted Reproductive Technology
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant FSH
7.2.2 Urinary FSH
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Infertility Treatment
7.3.2 Assisted Reproductive Technology
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant FSH
8.2.2 Urinary FSH
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Infertility Treatment
8.3.2 Assisted Reproductive Technology
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant FSH
9.2.2 Urinary FSH
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Infertility Treatment
9.3.2 Assisted Reproductive Technology
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck Serono
10.1.2 MSD
10.1.3 IBSA
10.1.4 Ferring
10.1.5 Livzon
10.1.6 Techwell
10.1.7 GenSci
10.2 Follicle-stimulating Hormone (FSH) Sales Date of Major Players (2017-2020e)
10.2.1 Merck Serono
10.2.2 MSD
10.2.3 IBSA
10.2.4 Ferring
10.2.5 Livzon
10.2.6 Techwell
10.2.7 GenSci
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Follicle-stimulating Hormone (FSH) Product Type Overview
Table Follicle-stimulating Hormone (FSH) Product Type Market Share List
Table Follicle-stimulating Hormone (FSH) Product Type of Major Players
Table Brief Introduction of Merck Serono
Table Brief Introduction of MSD
Table Brief Introduction of IBSA
Table Brief Introduction of Ferring
Table Brief Introduction of Livzon
Table Brief Introduction of Techwell
Table Brief Introduction of GenSci
Table Products & Services of Merck Serono
Table Products & Services of MSD
Table Products & Services of IBSA
Table Products & Services of Ferring
Table Products & Services of Livzon
Table Products & Services of Techwell
Table Products & Services of GenSci
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Follicle-stimulating Hormone (FSH) Market Forecast (Million USD) by Region 2021f-2026f
Table Global Follicle-stimulating Hormone (FSH) Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Follicle-stimulating Hormone (FSH) Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Follicle-stimulating Hormone (FSH) Market Forecast (Million USD) Share by Demand 2021f-2026f